About the Authors
- Antonello Pessi
-
* E-mail: a.pessi@peptipharma.it (AP); map2028@med.cornell.edu (MP)
Affiliation PeptiPharma, Pomezia, Rome, Italy
- Annunziata Langella
-
Affiliation Merck Serono, Guidonia Montecelio, Rome, Italy
- Elena Capitò
-
Affiliation BASF Italia, Pontecchio Marconi, Bologna, Italy
- Silvia Ghezzi
-
Affiliation Viral Pathogens and Biosafety, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
- Elisa Vicenzi
-
Affiliation Viral Pathogens and Biosafety, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy
- Guido Poli
-
Affiliations AIDS Immunopathogenesis Units, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy, Vita-Salute San Raffaele University, School of Medicine, Milan, Italy
- Thomas Ketas
-
Affiliation Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America
- Cyrille Mathieu
-
Affiliations INSERM, Ecole Normale Supérieure de Lyon, Lyon, France, Pedriatics, Weill Medical College of Cornell University, New York, New York, United States of America
- Riccardo Cortese
-
Affiliation CEINGE, Naples, Italy
- Branka Horvat
-
Affiliations INSERM, Ecole Normale Supérieure de Lyon, Lyon, France, IFR128 BioSciences Lyon-Gerland Lyon-Sud, University of Lyon, Lyon, France
- Anne Moscona
-
Affiliations Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America, Pedriatics, Weill Medical College of Cornell University, New York, New York, United States of America
- Matteo Porotto
-
* E-mail: a.pessi@peptipharma.it (AP); map2028@med.cornell.edu (MP)
Affiliation Pedriatics, Weill Medical College of Cornell University, New York, New York, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts: Antonello Pessi is the owner of a small company (PeptiPharma) and the holder of the intellectual properties for the cholesterol addition and the dimerization of peptides. Annunziata Langella is currently an employe at Merck Serono and, Elena Capitò is currently an employe at BASF Italy. They do not hold any intellectual properties regarding the cholesterol tagged peptides and do not have any other competing interest. Anne Moscona and Matteo Porotto receive funds from NIH to study the antiviral properties of the fusion inhibitor peptides. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AP MP AM BH RC. Performed the experiments: AL EC MP SG TK CM. Analyzed the data: AP MP AM BH TK CM. Wrote the paper: AP AM MP BH EV GP.